Abstract PD10-10: Factors associated with decreased relative dose intensity in older adults with early-stage breast cancer receiving chemotherapy
Mina S. Sedrak(University of California, Los Angeles), William Dale(City of Hope), Heidi D. Klepin(Wake Forest University), Tracey L. O’Connor(Roswell Park Comprehensive Cancer Center), Reena Jayani(Vanderbilt University Medical Center), Can‐Lan Sun(University of Minnesota), Arti Hurria(Unknown), Abrahm Levi(City of Hope), Kemeberly Charles(City of Hope), Efrat Dotan(Fox Chase Cancer Center), Allison Magnuson(University of Rochester Medical Center), William P. Tew(Memorial Sloan Kettering Cancer Center), Cary P. Gross(Yale Cancer Center), Rachel A. Freedman(Dana-Farber Cancer Institute), Tanya M. Wildes(University of Nebraska Medical Center), Vani Katheria(City of Hope), Heeyoung Kim(City of Hope), Hyman B. Muss(University of North Carolina at Chapel Hill), Harvey Jay Cohen(Duke University), Anait Arsenyan(City of Hope)
Cited by 1
Related Papers
Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study
|Journal of Clinical Oncology|2011|1.8k
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|Journal of Clinical Oncology|2015|1k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
|CA A Cancer Journal for Clinicians|2015|737
Breast cancer statistics 2024
|CA A Cancer Journal for Clinicians|2024|661